Insulin resistance and beta cell dysfunction are the two main mechanisms implicated in the pathogenesis of T2D, constituting a vicious cycle in which adaptive insulin hypersecretion to meet elevated metabolic demand is followed by the progressive loss of beta cell mass and function (55), and both conditions act synergistically in adipocyte dysfunction. The gene discussed is INS; the disease is Insulin resistance.